Tetra Radar · FDA Approvals · Decision date

Biofrontera Inc.: FDA decision date

Biofrontera Inc. (BFRI) · September 2026

With a PDUFA date for sBCC in September 2026, positive Phase 3 results in AK on neck/trunk and extremities, and encouraging Phase 2b data in acne, we have multiple near-term catalysts that could meaningfully expand the commercial opportunity for the Ameluz platform.

Source: 8-K of 14 May 2026

The date has passed; Tetra Radar has not recorded an approval.

Biofrontera Inc. on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.